Skip to main contentShah's Gastro, Cancer & Robotic Surgery Centre · Ahmedabad & Gandhinagar
Junction cancer treatment in Ahmedabad · Gota OPD, Ahmedabad · Apollo Hospital, Bhat, Gandhinagar
The junction where the food pipe meets the stomach is where reflux, Barrett’s change, achalasia and cancer all show up — so the first job is to be sure which one it is. When it is cancer, its treatment runs in steps: removal through the endoscope for the earliest disease, chemotherapy around an operation for most locally advanced cancers, and an operation whose route — through the chest and abdomen, or through the abdomen alone — depends on whether the tumour is Siewert I, II or III. Some patients need no operation at all.
Because the same practice treats reflux, Barrett’s change, achalasia and junction cancer, a patient is not steered towards one answer by the narrowness of the service. Endoscopy, the tumour board, chemotherapy planning with the medical oncologist, and both kinds of junction operation sit in one place.
Shah’s Gastro, Cancer & Robotic Surgery Centre. Trained in super-specialty surgical gastroenterology programmes, qualified twice over in the specialty, with 18 years of experience in GI and cancer surgery. The food pipe and the stomach are operated on by the same surgeon, which matters most at the junction between them.
Dr Harsh Shah
MS, MCh (Surgical Gastroenterology), DrNB (Surgical Gastroenterology)
Registered with Gujarat Medical Council, Reg. No. G-38738
Food Pipe Cancer Surgeon · Apollo Hospital, Bhat, Gandhinagar · Gota OPD, Ahmedabad
Google rating 4.89 from 216 reviews at the Gota clinic, and 4.94 from 17 reviews at Apollo, Bhat.
Many people with a junction cancer have taken acidity tablets for years. The tablets did not cause the cancer, and stopping them will not change the plan; but the long history is why the endoscopy is read carefully for Barrett’s change around the tumour, which affects how much is removed and what is watched afterwards.
A narrowing or lump at the junction can be reflux damage, Barrett’s change, achalasia, a benign wall tumour or a cancer. An endoscopy with multiple biopsies, and endoscopic ultrasound when needed, tells them apart. Barrett’s with abnormal cells is treated within cancer care because it can progress.
| Finding at the junction | What it usually is | What settles it, and where it is treated |
|---|---|---|
| Inflamed, scarred narrowing after long reflux | Reflux damage — benign | Biopsies to exclude cancer; then the reflux pathway |
| Salmon-coloured lining extending up from the stomach | Barrett’s change | Mapped biopsies; abnormal cells mean endoscopic treatment within cancer care |
| A tight junction with food held above it, both solids and liquids difficult | Achalasia — or a cancer imitating it | Endoscopy first; any mass or a junction the scope cannot pass is biopsied and scanned before any achalasia label |
| A smooth bulge under normal lining | A wall tumour such as a GIST or leiomyoma | Endoscopic ultrasound; managed on a separate pathway |
| An ulcerated or raised growth | Cancer | Biopsies, staging, and the steps on this page |
The endoscopy report should state, in distances from the front teeth, where the tumour starts and ends and where the junction lies. From these, the tumour’s centre is placed above, across, or below the junction — Siewert I, II or III — and that placement decides whether it is treated on the food pipe pathway or the stomach pathway.
| Siewert type | Where the centre lies | Pathway | Usual operation and route |
|---|---|---|---|
| Siewert I | In the lower food pipe, above the junction | Food pipe cancer pathway | Ivor Lewis esophagectomy — through the abdomen and the chest, with the join in the chest |
| Siewert II | Across the junction itself | Food pipe cancer pathway | Esophagectomy preferred over an extended stomach operation, so that nodes in the chest are cleared as well as those in the abdomen |
| Siewert III | In the upper stomach, below the junction | Stomach cancer pathway | Extended total gastrectomy — through the abdomen, removing the whole stomach with the lowest part of the food pipe |
If those distances are missing from an outside report, the type cannot be assigned honestly, and the endoscopy is repeated before any plan is given. A family told “it is in between” has been given a description of anatomy, not a plan; the type is a defined category, and each category has a defined approach.
Treatment climbs only as high as the cancer requires. Abnormal Barrett’s lining and the earliest cancers are treated through the endoscope; slightly deeper early cancers go straight to an operation; locally advanced cancers receive chemotherapy before and after surgery; and cancer that has spread is treated with medicines matched to the tumour.
| Step | Who it suits | What it involves |
|---|---|---|
| Endoscopic treatment | Barrett’s with abnormal cells; the earliest cancer confined to the lining | Endoscopic removal (EMR or ESD), with ablation of any remaining Barrett’s lining; the junction is kept |
| Operation first | An early cancer gone slightly deeper, or with unfavourable features after endoscopic removal | The operation for its Siewert type, with lymph node removal |
| Chemotherapy before and after the operation | Locally advanced adenocarcinoma in a fit patient | Combination chemotherapy cycles, the operation some weeks later, then the remaining cycles |
| Chemoradiation, then the operation | Adenocarcinoma in a patient not suited to the chemotherapy course; locally advanced squamous cancer | Chemotherapy with radiation, reassessment, then the operation |
| Medicines for spread disease | Cancer in the liver, lungs or abdominal lining | Chemotherapy with targeted or immune therapy chosen by HER2, PD-L1 and mismatch-repair results; palliative care from the start |
| Keeping swallowing open | A blocking tumour in a patient who will not have an operation | A stent or radiotherapy, with nutrition support |
An operation is not part of the plan for Barrett’s change and the earliest cancers that the endoscope can remove completely, for cancer that has spread to distant organs, for a tumour grown into a structure that cannot be removed, or for a patient whose heart and lungs cannot carry a major operation.
For adenocarcinoma at the junction, chemoradiation on its own has only a limited role, so a patient unfit for surgery is planned around medicines, measures to keep swallowing open, and close support rather than around radiation alone. Where an early cancer removed through the endoscope turns out deeper on the microscope report, the step goes up, not down — the tumour board moves that patient to an operation.
Beyond the endoscopy, CT and PET-CT used for any food pipe cancer, junction adenocarcinoma has two particular tests: a staging laparoscopy, which looks directly at the abdominal lining for deposits too small for any scan, and tumour biomarkers — HER2 above all — which shape the chemotherapy if the cancer has spread.
A staging laparoscopy is a short procedure under anaesthesia through small cuts. It is used for Siewert II adenocarcinoma and other high-risk junction cancers before committing to chemotherapy and a major operation, because finding hidden spread changes the whole plan. Fluid from the abdomen is examined for cancer cells at the same time.
Before any operation that enters the chest — Siewert I and II — heart tests and lung function tests with gas transfer are done; they, and not age, decide fitness. Daily activity level is recorded at every visit.
Siewert I and II tumours are usually treated with an Ivor Lewis esophagectomy: the lower food pipe and upper stomach are removed with nodes in the abdomen and chest, and the stomach is made into a tube and joined to the food pipe inside the chest. Siewert III tumours are treated with an extended total gastrectomy through the abdomen.
The reason is drainage. The lower food pipe drains upwards into the chest; the upper stomach drains downwards into the abdomen. A tumour straddling the join drains both ways, which is why a Siewert II tumour is treated as a food pipe cancer and the chest nodes are cleared. A Siewert III tumour lies mainly in the stomach, so the whole stomach is removed with the lowest part of the food pipe, and the food pipe is joined to a loop of small bowel; this operation follows the stomach cancer pathway, described with the upper stomach cancer operations.
Both operations are performed by keyhole or robot-assisted surgery where the tumour and tissues allow, and open where a bulky tumour or tissues stiffened by earlier treatment make that safer. The margin is checked during the operation by frozen section when there is any doubt, because a clear margin at the junction is the point of the whole exercise.
A junction tumour often makes swallowing hard just when chemotherapy needs a well-fed patient. If an operation is planned, a feeding tube into the small bowel is preferred to a stent, because a stent can complicate surgery; a dietitian sees every patient who has lost weight or is eating too little.
Prehabilitation starts in the OPD rather than on admission: walking every day, breathing exercises with a spirometer, stopping smoking and alcohol well ahead, correcting anaemia and building protein. Nutrition is never allowed to be the reason chemotherapy stops.
Both junction operations carry real risks, including the risk of death, and Dr Harsh Shah names each one at the consent discussion with figures adjusted to your age, fitness and prior treatment. The risks differ between the chest operation and the total gastrectomy.
After an esophagectomy: a leak at the join; chest infection and other lung problems; an irregular heartbeat; a hoarse voice from strain on the nerve to the voice box, usually recovering; a milky lymph leak into the chest; poor blood supply to the stomach tube; later, narrowing at the join and acid or bile coming back up. After a total gastrectomy: a leak at the join or from the closed end of the duodenum; slow emptying; feeling faint after meals; bile reflux; an internal hernia later; and lifelong need for vitamin B12 and attention to iron. Either: bleeding, wound infection and clots.
The pathology report on the removed tissue sets the next step. After chemotherapy and surgery, the remaining chemotherapy cycles are completed. After chemoradiation, cancer still present in the specimen leads to an offer of immunotherapy for about a year; if none is left, follow-up alone is enough.
Follow-up continues for many years, with visits and CT scans more frequent in the early years. Weight, swallowing, vitamin B12 and iron are watched for life, and small frequent meals with reflux precautions — head raised at night — become the daily routine.
What a cancer at the gastro-oesophageal junction looks like on upper GI endoscopy, explained by Dr Harsh Shah.
A patient describes the operation and recovery after an esophagectomy by Dr Harsh Shah, recorded and shared with written consent.
The cost depends on the step you need — endoscopic treatment, chemotherapy, an esophagectomy or a total gastrectomy — and on the approach, the room category and the length of stay. A written estimate is given before treatment starts and explained.
Apollo Hospital, Bhat, works with the major insurers and cashless schemes, and the office handles pre-authorisation directly; an enhancement request is raised at the time if the stay runs longer. Immunotherapy and targeted medicines carry their own cost, and access programmes are discussed openly.
Bring: the endoscopy report with measurements and photographs, biopsy reports, CT and PET-CT images on a disc or drive, any chemotherapy summary, a list of medicines, the insurance card and identification, and one family member as the point of contact.
★★★★★
“We are very thankful to Dr. Harsh Shah for treating and operating on my father for gastric (stomach) cancer. From the first consultation to the surgery and follow-up, he guided us with great care and explained everything clearly. My father is doing well now, and we are extremely grateful for the treatment and support provided by Dr. Harsh Shah and his team. He is a highly experienced and compassionate doctor. We would definitely recommend Dr. Harsh Shah to anyone looking for an experienced doctor for stomach cancer treatment. Thank you, Doctor, for everything! — Moh. Ahsan, Google review, Apollo Hospital, Bhat listing”
★★★★★
“Excellent doctor for stomach cancer. We r very happy. Recommend for gastro cancer treatment in Ahmedabad — Purshottam Meena, Google review, Shah's Cancer & Robotic Surgery Centre listing”
★★★★★
“Met with Dr. Harsh Shah for the consultation of one of my relative. Dr. Harsh Shah is an exceptional surgical oncologist in Ahmedabad. His expertise in treating complex GI cancers like liver, pancreas, and colon cancers is truly remarkable. He explains everything clearly and gives patients full confidence in their treatment. Highly recommended for anyone looking for a skilled and compassionate cancer specialist. — Nagesh Patidar, Google review, Gota clinic listing”
Real Google reviews from Dr Harsh Shah’s listings, reproduced exactly as written.
It describes where the centre of the tumour lies — above the junction (type I), across it (type II) or below it in the stomach (type III). The type decides whether the cancer is treated as a food pipe cancer or a stomach cancer, and which operation is used.
Usually only for Siewert III, where the whole stomach is removed with the lowest part of the food pipe. For Siewert I and II, the stomach is kept, reshaped into a tube and used to replace the removed food pipe.
Long-standing reflux can lead to Barrett's change, from which junction cancers can arise. The tablets themselves are not the cause. The endoscopy looks for Barrett's change around the tumour because it affects how much is removed and what is checked later.
For locally advanced junction adenocarcinoma, chemotherapy before and after surgery shrinks the tumour and treats cells no scan can see. Squamous cancer, and patients not suited to that course, receive chemoradiation instead.
It is a short look inside the abdomen through small cuts, done for Siewert II and other high-risk junction adenocarcinomas, to find deposits too small for any scan before committing to a major operation.
Yes. Barrett's with abnormal cells and cancers confined to the inner lining can often be removed through the endoscope, keeping the junction intact, followed by endoscopic surveillance.
Shah’s Gastro, Cancer & Robotic Surgery Centre — Gota, Ahmedabad
Consultations, endoscopy planning, review of scans, follow-up and surveillance.
Google: Dr Harsh Shah · 4.89 from 216 reviews
Directions to the Gota clinic · +91-63555-64601
Apollo Hospital — Bhat, Gandhinagar
Apollo Hospital International Limited, Plot No. 1 A, GIDC Bhat Industrial Estate, Bhat, Gandhinagar.
Google: Dr Harsh Shah – Robotic GI Surgeon · 4.94 from 17 reviews
Directions to Apollo, Bhat · WhatsApp +91-63555-64601
Patients come to Ahmedabad for junction cancer treatment from across Gujarat — Gandhinagar, Mehsana, Banaskantha, Nadiad, Anand, Bhavnagar, Rajkot, Jamnagar and Kutch — and from southern Rajasthan and western Madhya Pradesh.
Told there is a growth "at the GE junction" or "at the cardia"? The endoscopy report with its measurements and photographs, the biopsy report and any CT or PET-CT images can be sent ahead of your appointment, so the consultation starts with them already read. Treatment is decided at the consultation, after examination. Call +91-63555-64601 · Send the reports ahead on WhatsApp
Swasth Parivar: twice a month, practical advice on recovery, diet and warning signs. No advertising. Stop any time.
Your number is used for these updates and for the clinic to reach you. It is never sold or passed on. To stop, reply STOP on WhatsApp.
